rasagiline has been researched along with Autoimmune Lymphoproliferative Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hattori, S; Ito, S; Kanegane, H; Kitagawa, N; Kurita, D; Murase, A; Nishimura, K; Ohya, T; Sasaki, K; Shiba, N; Shimosato, Y; Takeuchi, M; Tanoshima, R; Tsujimoto, SI; Yoshitomi, M | 1 |
1 other study(ies) available for rasagiline and Autoimmune Lymphoproliferative Syndrome
| Article | Year |
|---|---|
Severe RAS-Associated Lymphoproliferative Disease Case with Increasing αβ Double-Negative T Cells with Atypical Features.
Topics: Autoimmune Lymphoproliferative Syndrome; CD4-Positive T-Lymphocytes; Child; Female; Humans; Lupus Erythematosus, Systemic; Lymphoproliferative Disorders; Receptors, Antigen, T-Cell, alpha-beta | 2023 |